tradingkey.logo
tradingkey.logo
Search

Passage Bio Inc

PASG
Add to Watchlist
4.250USD
+0.240+5.99%
Close 11-13 16:00(ET)
13.69MMarket Cap
LossP/E TTM

Passage Bio Inc (PASG) Stock Price Target & Forecast

Analyst Rating

Based on 3 analysts giving stock ratings to Passage Bio Inc in the past month.

Hold
0 Strong Buy
1 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
15.500USD+349.28%

PASG Analyst Recommendation Trends

In the current month, PASG has received 1 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. PASG average Analyst price target in the last month is 15.500.

2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
Strong Buy
0
0
0
0
1
1
3
2
Buy
1
1
1
1
1
1
4
4
Hold
2
2
2
2
3
4
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
3
3
3
3
5
6
7
6

Financial Forecasting

Based on analysts' estimates, PASG EPS is projected to reach -2.550 in FY2026Q4, following reported EPS of -1.467 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-2.79
-2.65
-2.44
-2.55
Actual
-2.36
-2.44
-1.47
--
Surprise
+15.49%
+7.91%
+39.90%
--

FAQs

What is Passage Bio Inc's price target?

Analysts forecast that Passage Bio Inc's price target is USD 53.50, with the highest forecast at USD 120.00 and the lowest forecast at USD 10.00.

How have Passage Bio IncPASG's recent earnings per share performed?

The market expectation was USD -1.47, while Passage Bio IncPASG's earnings per share (EPS) for the previous quarter was USD -2.44. EPS for the next quarter is expected at USD -2.55.

What is the analyst rating for Passage Bio Inc?

Based on the ratings of Passage Bio Inc's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.